Schizophreniform disorder is a type of psychotic illness with symptoms similar to those of schizophrenia, but lasting for less than 6 months. Like schizophrenia, schizophreniform disorder is a type of “psychosis” in which a person cannot tell what is real from what is imagined.
Wiki Number: PW196
Diagnosis: Schizophreniform Disorder
World Patients :
Age Onset: M, 18-14; W, 18-3
Symptoms: On month of schizophrenic events while the schizophrenia diagnosis requires at least 6 months. Start as only 1/5th as many as full.
Progression: The levels of disease and shorter duration are less than full schizophrenia. But 2/3 later develop full schizophrenia.
Causes: genetic and stress-triggers; more likely with other family members with schizophrenia
Therapies: individual, family and ocuppational therapies can reduce the impact
Youtube Video: Schizophreniform Disorder
Amazon or Library Book: From Hopelessness to Hopeful: (Schizophreniform Disorder)
Click the book to link or order from Amazon.
Support Group: sczaction-800-493-2084
(Schizophrenia Action Alliance)
4 CURRENT ARTICLES
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- The host genetics affects gut microbiome diversity in Chinese depressed patientsby Ke Han on January 26, 2023
The gut microbiome and host genetics are both associated with major depressive disorder (MDD); however, the molecular mechanisms among the associations are poorly understood, especially in the Asian, Chinese group. Our study applied linear discriminant analysis (LDA) effect size (LEfSe) and genome-wide association analysis in the cohort with both gut sequencing data and genomics data. We reported the different gut microbiota characteristics between MDD and control groups in the Chinese group and...
- Cariprazine - an Alternative Treatment for Clozapine-resistant Schizophrenia?by Adam Montgomery on January 26, 2023
Treatment-resistant schizophrenia (TRS) poses a significant therapeutic challenge in psychiatric practice. Clozapine is recognized as a treatment of choice in TRS but is not always effective in alleviating patients' symptoms. Additionally, clozapine therapy is associated with multiple side effects and monitoring requirements that often limit its use and negatively affect patients' compliance with the treatment. Although clozapine augmentation options are available, there is currently no...
- A decrease in NR2B expression mediated by DNA hypermethylation induces perioperative neurocognitive disorder in aged miceby Feifei Xu on January 25, 2023
CONCLUSIONS: Laparotomy cause hippocampus-dependent cognitive decline by hypermethylating the NR2B gene, allowing us to understand the pathogenesis of PND in an epigenetic landscape.
- Current evidence for various inpatient psychotherapy programs in the treatment of psychoses-A narrative review articleby Stephanie Mehl on January 25, 2023
BACKGROUND: The analysis of the efficacy of evidence-based psychotherapy for patients with psychotic disorders has mostly been carried out in the outpatient field. In the inpatient field the efficacy is sometimes difficult to assess due to different healthcare systems.